Teladoc Health Inc. (NYSE:TDOC) shares fell to a low of $150.39 before closing at $152.36. Intraday shares traded counted 2.72 million, which was 26.79% higher than its 30-day average trading volume of 3.71M. TDOC’s previous close was $150.58 while the outstanding shares total 152.17M. The firm has a beta of 0.23. The stock’s Relative Strength Index (RSI) is 48.07, with weekly volatility at 3.58% and ATR at 7.25. The TDOC stock’s 52-week price range has touched low of $129.74 and a $308.00 high. The stock traded higher over the last trading session, gaining 1.18% on 06/01/21.
Investors have identified the Health Information Services company Teladoc Health Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $23.30 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Teladoc Health Inc. (TDOC) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For TDOC, the company has in raw cash 720.1 million on their books with 0.0 currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on a decline. In terms of their assets, the company currently has 1.03 billion total, with 260.36 million as their total liabilities.
TDOC were able to record -31.29 million as free cash flow during the 08/04/2021 quarter of the year, this saw their quarterly net cash flow reduce by -13.22 million. In cash movements, the company had a total of -18.03 million as operating cash flow.
Potential earnings growth for Teladoc Health Inc. (TDOC)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/04/2021 quarter of the year, Teladoc Health Inc. recorded a total of 453.68 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 60.15% coming in sequential stages and their sales for the 08/04/2021 quarter increasing by 15.51%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 145.96 million trying to sell their products during the last quarter, with the result yielding a gross income of 307.72 million. This allows shareholders to hold on to 152.17M with the recently reported earning now reading -1.31 cents per share. This is a figure that compared to analyst’s prediction for their 08/04/2021 (0.13 cents a share).
Having a look at the company’s valuation, the company is expected to record -0.96 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on TDOC sounds very interesting.
Is the stock of TDOC attractive?
In related news, Chief Human Resources Officer, Geshuri Arnnon sold 3,959 shares of the company’s stock in a transaction that recorded on May 26. The sale was performed at an average price of 146.40, for a total value of 579,602. As the sale deal closes, the SVP Corporate Strategy, Trencher Daniel now sold 2,000 shares of the company’s stock, valued at 300,000. Also, Chief Executive Officer, GOREVIC JASON N sold 10,000 shares of the company’s stock in a deal that was recorded on May 04. The shares were price at an average price of 156.48 per share, with a total market value of 1,564,761. Following this completion of acquisition, the Director, Taneja Hemant now holds 25,000 shares of the company’s stock, valued at 4,635,654. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.80%.
19 out of 33 analysts covering the stock have rated it a Buy, while 12 have maintained a Hold recommendation on Teladoc Health Inc.. 1 analysts has assigned a Sell rating on the TDOC stock. The 12-month mean consensus price target for the company’s shares has been set at $231.41.